Denied
The Board denied a compensable evaluation for hairy cell leukemia with hypogammaglobulinemia from August 24, 2024, as the Veteran's condition was found to be asymptomatic and in Rai Stage 0.
The deciding factor: The evidence showed that the Veteran's treatment (antineoplastic chemotherapy) has been completed and is currently in watchful waiting status, with no active disease or ongoing treatment since 2023.
- Claimed conditions
- hairy cell leukemia with hypogammaglobulinemia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- December 19, 2025
- Citation
- A25109832
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.